Elevated HbA1c remains a predominant finding in severe COVID-19 and may be associated with increased mortality in patients requiring mechanical ventilation

Sebastian Klein(Biocrates Life Sciences (Austria)), Claudius Thomé, Georg Lehner(Innsbruck Medical University), Eva Foidl(University of Applied Sciences Kufstein), Adelheid Ditlbacher, Stephan Eschertzhuber, Isabella Weilguni, Miriam Potocnik, Simon Mathis(Innsbruck Medical University), Timo Mayerhöfer(Innsbruck Medical University), Michael Joannidis(Innsbruck Medical University), Fabian Perschinka(Innsbruck Medical University), Bruno Reitter, Anna Fiala(Innsbruck Medical University), Julia Haßlacher(Innsbruck Medical University), Eugen Ladner, Armin Kalenka(University of Applied Sciences Kufstein), Andreas Peer(Innsbruck Medical University), D Friès, Agnes Pechlaner, Stefanie Haslauer-Mariacher, Lukas Kirchmair(Hanusch Hospital), Alexandra Ribitsch, Bernhard Mayr-Hueber, Christoph Krismer, Andreas Mayr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Birgit Stögermüller(Hanusch Hospital), Walter Hasibeder(Ordensklinikum Linz Barmherzige Schwestern), Jürgen Brunner(Innsbruck Medical University), Romuald Bellmann(Innsbruck Medical University), Christian Preuß Hernández(Innsbruck Medical University), Stefanie Zagitzer-Hofer
Critical Care
August 19, 2021
Cited by 12


Related Papers